Dynamics of a Staphylococcus aureus infective endocarditis simulation model

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,51 MB, PDF-dokument

Infective endocarditis (IE) is a serious infection of the inner surface of heart, resulting from minor lesions in the endocardium. The damage induces a healing reaction, which leads to recruitment of fibrin and immune cells. This sterile healing vegetation can be colonized during temporary bacteremia, inducing IE. We have previously established a novel in vitro IE model using a simulated IE vegetation (IEV) model produced from whole venous blood, on which we achieved stable bacterial colonization after 24 h. The bacteria were organized in biofilm aggregates and displayed increased tolerance toward antibiotics. In this current study, we aimed at further characterizing the time course of biofilm formation and the impact on antibiotic tolerance development. We found that a Staphylococcus aureus reference strain, as well as three clinical IE isolates formed biofilms on the IEV after 6 h. When treatment was initiated immediately after infection, the antibiotic effect was significantly higher than when treatment was started after the biofilm was allowed to mature. We could follow the biofilm development microscopically by visualizing growing bacterial aggregates on the IEV. The findings indicate that mature, antibiotic-tolerant biofilms can be formed in our model already after 6 h, accelerating the screening for optimal treatment strategies for IE.

OriginalsprogEngelsk
TidsskriftAPMIS
Vol/bind130
Udgave nummer8
Sider (fra-til)515-523
ISSN0903-4641
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
This work was supported by the Novo Nordisk Fonden (NNF17OC0025074) to MD, PhD Claus Moser and the A.P. Møller Fonden (19‐L‐0283) to MD, PhD Christian J. Lerche, the Swedish Society for Medical Research (PD20‐0031), the Tornspiran Foundation, the Foundation for the memory of Sigurd and Elsa Golje (LA2021‐0027), the Lund University foundations (RMh2021‐0001 and RMv2021‐0002), the Längmanska Foundation (BA21‐0430), the Royal Physiographic Society of Lund (42001), and the Thelma Zoégas Fund for Medical Research (TZ2021‐0008) to MD, PhD Torgny Sunnerhagen and the Rigshospitalet introduktionsstipendium (E‐22416‐07) to MSc, Franziska A. Schwartz.

Publisher Copyright:
© 2022 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Medical Microbiology and Pathology.

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 309115304